look like down. now is 8.18

is stable.

pharma is up

for investment in share shall have at least 15% to 25% minimum. as long as not loss than is good enough.

1.50 level with be good for entry.

STILL DOWN. NO WAY TO UP FURTHER.

TP is 9.17. but do nto when to reach

normal up and down. but something is going at AEON for 12 months

the e-mail which i receive is just ask the subscriber to buy the icap share in order to have voting rights.

hopefully can reach 3.++

Aeon price up or down.

3Q12 margin surge on better product mix
9M12 core net profit rises 17% yoy - inline
Globe reported a stronger 9M12 net profit of RM30.1m (+39% yoy) although
partially contributed by a RM4.2m gain on disposal of its Jitra plant. Adjusted for
the EI, 9M12 core net profit growth of +16.7% yoy to RM25.2m was equally
impressive and underpinned primarily by margin expansion. 9M12 EBITDA
margin improved to 32.5% from 25.4% for 9M11 on the back of cost discipline as
well as a shift in product mix towards higher margin products. A key contributor
to this is the maiden contribution from its proximity sensors that achieved mass
production in July 2012. Better economies of scale from its wafer processing job
and quartz crystal timing devices are also likely to have aided margin
enhancement.
The successful execution of its proximity sensor product is another testimony of
Globe’s dynamic management team ability to identify new business opportunities
and penetrate new market segments. We continue to like the stock for its strong
earnings growth prospects (3-year CAGR of 22.7% over FY11-FY14) and its
highly attractive dividend yield (9.5% for FY13).

If pandin drop to 1.80 level than i safe to enter. unless the sale simprove and the economy outlook is improve.

when ge announced than willd rop lower again

If the accq really true than the sales will increase 50% and thus the share price.

Due to the changed retail landscape, earnings risk may be significant for Padini, particularly in the Klang Valley. As such, we have taken down our forward estimates on earnings. Share price is expected to oscillate around the current level until the market has fully digested the potential impact of H&M. On the flipside, Padini being geographically well-diversified nationwide could be able to offset the slowdown in spending within the Klang Valley and limit the downside risk.We re-affirm our HOLD recommendation on Padini Holdings, with a lower fair value of RM2.00/share vs. RM2.57/share previously

do not think will be so soon. if the ge going to be soon than the share price may come down further.

IGB is on the way run

Pharmaniaga has entered into a MOU with Pusat Pakar Dialysis Traktif SB (PPDT) for the intention and understanding to explore the opportunity in dialysis business and to enter into a strategic partnership in the business of hemodialysis and such other business arrangements.
Through this MOU, we think that Pharmaniaga has the potential to
supply medical equipment to PPDT who currently has 50 hemodialysis centers nationwide. This would potentially provide a new dimension in its earnings base.


anything can happen the best is below 2.00

any reason why EPF shall be buying. Maybe there are the one who is throwing.anything can one in malaysian IPO.

frankly speaking astro need to think a way to have more subscriber. in sarawak i think a lot of us have dish isyead of subscribe to ASTRO. the enforcement do not catch at all.

will not buy padini. wait for announcement.

IGB is on the way down. will buy more

The recent weakness in Padini’s share price is largely due to concerns
with H&M’s entry to the Malaysian market. The surprise here is that H&M
have priced their goods very competitively and this could pose a threat to
established players. We argue that competition is not new to Padini and
their larger store network is a competitive advantage here. At 11x FY13
PE trades at a discount to peers and a yield of 4.3% makes it compelling
at these levels. We re-iterate our BUY call and RM2.83 target price.

yeap. restaurant is bad.

coffee market too crowded and the company is new and a lot of the outlet is empty.

must be someone who know something that other do not know.

also out from padini.

IGB’s portfolio of office buildings are all carried in its book
at historical cost (see Table AA) of just RM570m versus
our estimated market value of RM1.67bil. For example,
The Gardens North Tower is carried in its book at just
RM140m or RM329psf, while Gardens South Tower is at
RM136.9m or RM335psf. This is despite both buildings
enjoying excellent prime rents of RM6-6.50psf. Based on
capitalization rates of between 6-7%, the potential
revaluation surplus is estimated to be about RM1.1bil,
representing almost 74sen/share (or 30% of IGB’s current
market capitalization.

Management is also looking at the possibility of launching
an office REIT, which would likely take place only after the
debut of its retail REIT. Such a move would crystallize the
deep embedded value of its office assets.

Average TP is 10.90

possible. 200k after 6 yrs become 800k.must know how to search a good company and do less contra maybe 80/20. 20% contra.

Pharma 8.30.

pharma 8.10

that's good because at least there is demand at 2.04 and pnb sell at 2.59. the 2.04 takeover is just the requirement. more or less like a movie...

see pharma can raise to above 9.00 for 2013 play

PNB sell Bonia at 2.59 TO THE FAMILY

wait for 1.90

GTRONIC 1.52

i think something is going between YTL and YTL Power. Why YTL give its shareholder YTL warrant and pay 0.20 sen to subscribe to ytl power wb and later convert.

i think something is going between YTL and YTL Power. Why YTL give its shareholder YTL warrant and pay 0.20 sen to subscribe to ytl power wb and later convert.

i think something is going between YTL and YTL Power. Why YTL give its shareholder YTL warrant and pay 0.20 sen to subscribe to ytl power wb and later convert.

still accmulate more if the price is right.

will huat again

will be up

i also have buy below 7.00

AEON IS 11.74

IGB 2.35

agree with you. other share i think is willbe bonia, aeon, dksh

AEON, IGB, DKSH